David Hutton

The study could lead to early diagnosis and treatment of age-related macular degeneration.

Mount Sinai study is the first to identify that heart attack, stroke and heart failure are linked to a specific type of age-related macular degeneration.

According to a study, use is linked to a lower prevalence of age-related macular degeneration in European populations.

According to NEXGEL, the patch is expected be available for ophthalmologists to offer to their patients in the first half of 2023.

ONS-5010 is an investigational ophthalmic formulation of bevacizumab under development to be administered as an intravitreal injection for the treatment of wet AMD and other retinal diseases.

Oyster Point Pharma Inc. announced that the largest Medicare pharmacy benefit manager in the United States will add its varenicline solution nasal spray for the treatment of dry eye.

Oyster Point Pharma Inc. this week announced the expansion of patient access to varenicline solution (Tyrvaya) nasal spray.

The FDA has accepted the supplemental Biologics License Application of aflibercept injection for review in patients with diabetic retinopathy.

The CLEAR Act would clarify the FDA’s authority to regulate products, including eye drops, after a court decision created unnecessary confusion and turmoil.

A team of investigators has found that there is a bidirectional association between chronic kidney disease and glaucoma.

A University of Houston study found that minorities have fewer eye exams, higher instances of disease.

While investigators have found a link between dry eye and depression, the exact reasons behind the link are not immediately known.

Cyclosporine ophthalmic emulsion is indicated to increase tear production in patients with dry eye.